Dry Needling and Quad Strength After Anterior Cruciate Ligament Reconstruction
ACLR
Effects of Dry Needling on Quadriceps Muscle Strength in Acute Post-Operative Anterior Cruciate Ligament Reconstruction With Quadriceps Autograft in the Pediatric Population
1 other identifier
interventional
40
1 country
3
Brief Summary
Dry needling is a skilled intervention provided by trained physical therapists to treat pain, myofascial dysfunction, and a variety of other diagnosis. While there is research demonstrating the benefits of dry needling in reduction of pain and improvement in strength, research in regards the pediatric population is very limited. A recent retrospective chart review regarding dry needling trends and outcomes in the pediatric orthopedic population showed the pediatric population is tolerating this treatment and seeing benefits. Physical therapists are already pushing the boundaries and finding additional benefits in the use of dry needling with current patients. A diagnosis frequently seen in sports medicine is surgical reconstruction of the anterior cruciate ligament (ACL). Over the last couple of years, therapists have seen an increase in the use of quadriceps tendon autograft for reconstruction following ACL tears due to lower incidence rate of retears. Patients have been struggling to regain strength of the quadriceps to meet desired outcomes. The quadricep muscles are one of the major stabilizers of the knee and with a reduction in strength places the patient at a significant increase of retear. Subjects will be categorized into an experimental group (dry needling intervention + physical therapy) or the control group (physical therapy only) with a N of 20 in each group. The goal for this research is to determine if dry needling use in the subacute phase of post-operative ACLR following quadriceps autograft can assist with increasing quad strength and improve post-surgical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedStudy Start
First participant enrolled
August 14, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
Study Completion
Last participant's last visit for all outcomes
June 30, 2027
July 22, 2026
July 1, 2026
11 months
June 15, 2026
July 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Quadriceps Muscle Strength
Muscle strength measurement will be taken with use of the handheld dynamometer and use of stabilizing gait belt. A max force production will be created over three seconds. Three trials will be recorded, and average will be used as the final number. For the intervention group, measurements will be taken immediately prior to dry needling and immediately following dry needling for both sessions of intervention (week 6 and week 7). Additional post intervention measurements will be taken 2 weeks following dry needling intervention (week 9). For the Control Group, measurements will be taken during week 6, week 7, and week 9. Measurements will be taken at the start of the physical therapy visit.
Muscle strength measurements taken at post-operative week 6, 7, and 9.
Study Arms (2)
Dry Needling Group
EXPERIMENTALFor the Intervention Group, dry needling will be completed to the quadriceps muscle. Strength measurements will be taken using a handheld dynamometer in post-operative weeks 6, 7, and 9.
Control Group (No dry needling)
NO INTERVENTIONParticipants will not receive dry needling intervention. Strength measurements will be taken using a handheld dynamometer in post-operative weeks 6, 7, and 9.
Interventions
Dry needling is defined as a skilled intervention that utilizes a thin filiform needle to stimulate underlying myofascial trigger points, muscular, and connective tissue in managing pain and movement dysfunction. For the Intervention Group, dry needling will be completed to the quadriceps as stated below. Two sessions of dry needling will be done once per week starting in week 6 and finishing by end of week 7. The patient will be laying in supine. Needles will be placed in the quadriceps muscle. Placement will be at identified trigger points or in mid muscle belly if no trigger point is identified. Electrical stimulation will be applied and increased to an intensity of the patient's tolerance with a visual contraction noted. Electrical stimulation will remain on for 5 minutes.
Eligibility Criteria
You may qualify if:
- Status post subacute quadriceps autograft 6 weeks or less
- Ages 10-20 years
- English and/or Spanish speaking
You may not qualify if:
- History of surgery on the knee or hip on the testing lower extremity.
- Any surgical intervention to other ligamentous or meniscus structures during time of ACLR
- Any post-surgical complications such as infection
- Current pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Children's Mercy Sports Medicine Center- Village West
Kansas City, Kansas, 66111, United States
Children's Mercy - Blue Valley
Overland Park, Kansas, 66223, United States
Children's Mercy Hospital- Kansas City
Kansas City, Missouri, 64108, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mellony J Mann, DPT
Children's Mercy Hospital Kansas City
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Therapist
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 18, 2026
Study Start (Estimated)
August 14, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
July 22, 2026
Record last verified: 2026-07